{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:34Z","timestamp":1786982134149,"version":"build-2736575974"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"DOI":"10.1007\/s11910-026-01495-1","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T09:26:33Z","timestamp":1777022793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?"],"prefix":"10.1007","volume":"26","author":[{"given":"Lies","family":"Van Horebeek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysika","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Neufeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"1495_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","volume":"31","author":"J Oh","year":"2018","unstructured":"Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018;31:752\u20139. https:\/\/doi.org\/10.1097\/WCO.0000000000000622.","journal-title":"Curr Opin Neurol"},{"key":"1495_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162\u201373. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2.","journal-title":"Lancet Neurol"},{"key":"1495_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, S\u00f8rensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83:278\u201386. https:\/\/doi.org\/10.1212\/WNL.0000000000000560.","journal-title":"Neurology"},{"key":"1495_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J, et al. Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol. 2023;22:78\u201388. https:\/\/doi.org\/10.1016\/S1474-4422(22)00289-7.","journal-title":"Lancet Neurol"},{"key":"1495_CR5","doi-asserted-by":"publisher","first-page":"e200025","DOI":"10.1212\/NXI.0000000000200025","volume":"9","author":"D Pitt","year":"2022","unstructured":"Pitt D, Lo CH, Gauthier SA, Hickman RA, Longbrake E, Airas LM, et al. Toward Precision Phenotyping of Multiple Sclerosis. Neurol Neuroimmunol Neuroinflammation Wolters Kluwer. 2022;9:e200025. https:\/\/doi.org\/10.1212\/NXI.0000000000200025.","journal-title":"Neurol Neuroimmunol Neuroinflammation Wolters Kluwer"},{"key":"1495_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jocn.2024.07.013","volume":"126","author":"A Tun\u00e7","year":"2024","unstructured":"Tun\u00e7 A, Sefero\u011flu M, S\u0131vac\u0131 A\u00d6, K\u00f6kt\u00fcrk MD, Akba\u015f AA, Bozkurt B, et al. Oligoclonal band count as a marker of disease activity and progression in multiple sclerosis: A multicenter study. J Clin Neurosci. 2024;126:353\u201360. https:\/\/doi.org\/10.1016\/j.jocn.2024.07.013.","journal-title":"J Clin Neurosci"},{"key":"1495_CR7","doi-asserted-by":"publisher","first-page":"103048","DOI":"10.1016\/j.nicl.2022.103048","volume":"35","author":"A Calvi","year":"2022","unstructured":"Calvi A, Tur C, Chard D, Stutters J, Ciccarelli O, Cortese R, et al. Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis. NeuroImage Clin. 2022;35:103048. https:\/\/doi.org\/10.1016\/j.nicl.2022.103048.","journal-title":"NeuroImage Clin"},{"key":"1495_CR8","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3174\/ajnr.A6099","volume":"40","author":"J Maranzano","year":"2019","unstructured":"Maranzano J, Dadar M, Rudko DA, De Nigris D, Elliott C, Gati JS, et al. Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI. Am J Neuroradiol. 2019;40:1162\u20139. https:\/\/doi.org\/10.3174\/ajnr.A6099.","journal-title":"Am J Neuroradiol"},{"key":"1495_CR9","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","volume":"77","author":"L Kappos","year":"2020","unstructured":"Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C, et al. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials. JAMA Neurol. 2020;77:1132\u201340. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1568.","journal-title":"JAMA Neurol"},{"key":"1495_CR10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","volume":"72","author":"DT Okuda","year":"2009","unstructured":"Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, et al. Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome. Neurology. 2009;72:800\u20135. https:\/\/doi.org\/10.1212\/01.wnl.0000335764.14513.1a.","journal-title":"Neurology"},{"key":"1495_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.25799","volume":"88","author":"C Lebrun-Frenay","year":"2020","unstructured":"Lebrun-Frenay C, Kantarci O, Siva A, Sormani MP, Pelletier D, Okuda DT, et al. Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event. Ann Neurol. 2020;88:407\u201317. https:\/\/doi.org\/10.1002\/ana.25799.","journal-title":"Ann Neurol"},{"key":"1495_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41582-021-00519-3","volume":"17","author":"N Makhani","year":"2021","unstructured":"Makhani N, Tremlett H. The multiple sclerosis prodrome. Nat Rev Neurol. 2021;17:515\u201321. https:\/\/doi.org\/10.1038\/s41582-021-00519-3.","journal-title":"Nat Rev Neurol"},{"key":"1495_CR13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban X, Lebrun-Fr\u00e9nay C, Oh J, Arrambide G, Moccia M, Pia Amato M, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24:850\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(25)00270-4.","journal-title":"Lancet Neurol"},{"key":"1495_CR14","doi-asserted-by":"publisher","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, et al. Multiple sclerosis. Nat Rev Dis Primer. Nat Rev Dis Primers. 2018;4. https:\/\/doi.org\/10.1038\/S41572-018-0041-4.","DOI":"10.1038\/S41572-018-0041-4"},{"key":"1495_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0022-510X(75)90138-0","volume":"25","author":"CWM Adams","year":"1975","unstructured":"Adams CWM. The onset and progression of the lesion in multiple sclerosis. J Neurol Sci Elsevier. 1975;25:165\u201382. https:\/\/doi.org\/10.1016\/0022-510X(75)90138-0.","journal-title":"J Neurol Sci Elsevier"},{"key":"1495_CR16","doi-asserted-by":"publisher","unstructured":"Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol. Volume 55. Wiley, Ltd;; 2004. pp. 458\u201368. https:\/\/doi.org\/10.1002\/ANA.20016.","DOI":"10.1002\/ANA.20016"},{"key":"1495_CR17","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1177\/1352458514528762","volume":"20","author":"T Kalincik","year":"2014","unstructured":"Kalincik T, Buzzard K, Jokubaitis V, Trojano M, Duquette P, Izquierdo G, et al. Risk of relapse phenotype recurrence in multiple sclerosis. Mult Scler J SAGE Publications Ltd STM. 2014;20:1511\u201322. https:\/\/doi.org\/10.1177\/1352458514528762.","journal-title":"Mult Scler J SAGE Publications Ltd STM"},{"key":"1495_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/jnnp.2008.157305","volume":"80","author":"EM Mowry","year":"2009","unstructured":"Mowry EM, Deen S, Malikova I, Pelletier J, Bacchetti P, Waubant E. The onset location of multiple sclerosis predicts the location of subsequent relapses. J Neurol Neurosurg Psychiatry. 2009;80:400\u20133. https:\/\/doi.org\/10.1136\/jnnp.2008.157305.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1495_CR19","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1136\/jnnp.2007.136440","volume":"79","author":"S Deen","year":"2008","unstructured":"Deen S, Bacchetti P, High A, Waubant E. Predictors of the location of multiple sclerosis relapse. J Neurol Neurosurg Psychiatry. 2008;79:1190\u20133. https:\/\/doi.org\/10.1136\/jnnp.2007.136440.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1495_CR20","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/wnl.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444\u201352. https:\/\/doi.org\/10.1212\/wnl.33.11.1444.","journal-title":"Neurology"},{"key":"1495_CR21","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/brain\/awm329","volume":"131","author":"LK Fisniku","year":"2008","unstructured":"Fisniku LK, Brex PA, Altmann DR, Miszkiel KA, Benton CE, Lanyon R, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008;131:808\u201317. https:\/\/doi.org\/10.1093\/brain\/awm329.","journal-title":"Brain"},{"key":"1495_CR22","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/S00415-014-7351-6\/FIGURES\/6","volume":"261","author":"ID Kilsdonk","year":"2014","unstructured":"Kilsdonk ID, Lopez-Soriano A, Kuijer JPA, Graaf WLD, Castelijns JA, Polman CH, et al. Morphological features of MS lesions on FLAIR at 7 T and their relation to patient characteristics. J Neurol Dr Dietrich Steinkopff Verlag GmbH Co KG. 2014;261:1356\u201364. https:\/\/doi.org\/10.1007\/S00415-014-7351-6\/FIGURES\/6.","journal-title":"J Neurol Dr Dietrich Steinkopff Verlag GmbH Co KG"},{"key":"1495_CR23","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1177\/1352458514531084","volume-title":"Identical lesion morphology in primary progressive and relapsing\u2013remitting MS \u2013an ultrahigh field MRI study. Mult Scler","author":"J Kuchling","year":"2014","unstructured":"Kuchling J, Ramien C, Bozin I, D\u00f6rr J, Harms L, Rosche B, et al. Identical lesion morphology in primary progressive and relapsing\u2013remitting MS \u2013an ultrahigh field MRI study. Mult Scler. Volume 20. London, England: SAGE PublicationsSage UK; 2014. pp. 1866\u201371. https:\/\/doi.org\/10.1177\/1352458514531084."},{"key":"1495_CR24","doi-asserted-by":"publisher","first-page":"e1120","DOI":"10.1212\/NXI.0000000000001120","volume":"9","author":"O Al-Louzi","year":"2022","unstructured":"Al-Louzi O, Letchuman V, Manukyan S, Beck ES, Roy S, Ohayon J, et al. Central Vein Sign Profile of Newly Developing Lesions in Multiple Sclerosis: A 3-Year Longitudinal Study. Neurol Neuroimmunol Neuroinflammation. 2022;9:e1120. https:\/\/doi.org\/10.1212\/NXI.0000000000001120.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1495_CR25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1212\/WNL.0B013E31820B7630","volume":"76","author":"EC Tallantyre","year":"2011","unstructured":"Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan PS, Morris PG, et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology. 2011;76:534\u20139. https:\/\/doi.org\/10.1212\/WNL.0B013E31820B7630.","journal-title":"Neurology"},{"key":"1495_CR26","doi-asserted-by":"publisher","unstructured":"Landes-Chateau C, Levraut M, Okuda DT, Themelin A, Cohen M, Kantarci OH et al. The diagnostic value of the central vein sign in radiologically isolated syndrome. Ann Clin Transl Neurol. John Wiley & Sons, Ltd; 2024;11:662\u201372. https:\/\/doi.org\/10.1002\/ACN3.51986","DOI":"10.1002\/ACN3.51986"},{"key":"1495_CR27","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2019.2478","volume":"76","author":"T Sinnecker","year":"2019","unstructured":"Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, et al. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis. JAMA Neurol. 2019;76:1446\u201356. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2478.","journal-title":"JAMA Neurol"},{"key":"1495_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/13524585231214360","volume":"30","author":"L Daboul","year":"2024","unstructured":"Daboul L, O\u2019Donnell CM, Amin M, Rodrigues P, Derbyshire J, Azevedo C, et al. A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis. Mult Scler J. 2024;30:25\u201334. https:\/\/doi.org\/10.1177\/13524585231214360.","journal-title":"Mult Scler J"},{"key":"1495_CR29","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrneurol.2016.166","volume":"12","author":"P Sati","year":"2016","unstructured":"Sati P, Oh J, Constable RT, Evangelou N, Guttmann CRG, Henry RG, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016;12:714\u201322. https:\/\/doi.org\/10.1038\/nrneurol.2016.166.","journal-title":"Nat Rev Neurol"},{"key":"1495_CR30","doi-asserted-by":"publisher","first-page":"e1183","DOI":"10.1212\/WNL.0000000000005256","volume":"90","author":"R Cortese","year":"2018","unstructured":"Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, Angelis FD, et al. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurol Lippincott Williams Wilkins. 2018;90:e1183\u201390. https:\/\/doi.org\/10.1212\/WNL.0000000000005256.","journal-title":"Neurol Lippincott Williams Wilkins"},{"key":"1495_CR31","doi-asserted-by":"publisher","unstructured":"Maggi P, Absinta M, Grammatico M, Vuolo L, Emmi G, Carlucci G et al. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol. John Wiley & Sons, Ltd; 2018;83:283\u201394. https:\/\/doi.org\/10.1002\/ANA.25146","DOI":"10.1002\/ANA.25146"},{"key":"1495_CR32","doi-asserted-by":"publisher","unstructured":"Campion T, Smith RJP, Altmann DR, Brito GC, Turner BP, Evanson J, et al. FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis? Eur Radiol. Volume 27. Springer; 2017. pp. 4257\u201363. https:\/\/doi.org\/10.1007\/S00330-017-4822-Z\/FIGURES\/4.","DOI":"10.1007\/S00330-017-4822-Z\/FIGURES\/4"},{"key":"1495_CR33","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1177\/1352458515616700","volume-title":"Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. MSJ","author":"N Mistry","year":"2015","unstructured":"Mistry N, Abdel-Fahim R, Samaraweera A, Mougin O, Tallantyre E, Tench C, et al. Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. MSJ. Volume 22. London, England: SAGE PublicationsSage UK; 2015. pp. 1289\u201396. https:\/\/doi.org\/10.1177\/1352458515616700."},{"key":"1495_CR34","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1177\/1352458512441270\/ASSET\/IMAGES\/LARGE\/10.1177_1352458512441270-FIG4.JPEG","volume":"18","author":"J Wuerfel","year":"2012","unstructured":"Wuerfel J, Sinnecker T, Ringelstein EB, Jarius S, Schwindt W, Niendorf T, et al. Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler J SAGE PublicationsSage UK: Lond Engl. 2012;18:1592\u20139. https:\/\/doi.org\/10.1177\/1352458512441270\/ASSET\/IMAGES\/LARGE\/10.1177_1352458512441270-FIG4.JPEG.","journal-title":"Mult Scler J SAGE PublicationsSage UK: Lond Engl"},{"key":"1495_CR35","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3174\/ajnr.A6045","volume":"40","author":"S Suthiphosuwan","year":"2019","unstructured":"Suthiphosuwan S, Sati P, Guenette M, Montalban X, Reich DS, Bharatha A, et al. The Central Vein Sign in Radiologically Isolated Syndrome. Am J Neuroradiol. 2019;40:776\u201383. https:\/\/doi.org\/10.3174\/ajnr.A6045.","journal-title":"Am J Neuroradiol"},{"key":"1495_CR36","doi-asserted-by":"publisher","unstructured":"Oh J, Suthiphosuwan S, Sati P, Absinta M, Dewey B, Guenette M, Publications Ltd STM et al. 2021;27:2199\u2013208. https:\/\/doi.org\/10.1177\/13524585211002097.","DOI":"10.1177\/13524585211002097"},{"key":"1495_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/13524585231224681","volume":"30","author":"A Miscioscia","year":"2024","unstructured":"Miscioscia A, Treaba CA, Barletta VT, Herranz E, Sloane JA, Barbuti E, et al. White matter paramagnetic rim and non-rim lesions share a periventricular gradient in multiple sclerosis: a 7-Tesla imaging study. Mult Scler Houndmills Basingstoke Engl. 2024;30:166\u201376. https:\/\/doi.org\/10.1177\/13524585231224681.","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"1495_CR38","doi-asserted-by":"publisher","unstructured":"Dal-Bianco A, Oh J, Sati P, Absinta M, Ltd STM. 2024;17:17562864241306684. https:\/\/doi.org\/10.1177\/17562864241306684.","DOI":"10.1177\/17562864241306684"},{"key":"1495_CR39","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/ana.25877","volume":"88","author":"P Maggi","year":"2020","unstructured":"Maggi P, Sati P, Nair G, Cortese ICM, Jacobson S, Smith BR, et al. PARAMAGNETIC RIM LESIONS ARE SPECIFIC TO MULTIPLE SCLEROSIS: AN INTERNATIONAL MULTICENTER 3T MRI STUDY. Ann Neurol. 2020;88:1034\u201342. https:\/\/doi.org\/10.1002\/ana.25877.","journal-title":"Ann Neurol"},{"key":"1495_CR40","doi-asserted-by":"publisher","first-page":"e200253","DOI":"10.1212\/NXI.0000000000200253","volume":"11","author":"S Borrelli","year":"2024","unstructured":"Borrelli S, Martire MS, St\u00f6lting A, Vanden Bulcke C, Pedrini E, Guisset F, et al. Central Vein Sign, Cortical Lesions, and Paramagnetic Rim Lesions for the Diagnostic and Prognostic Workup of Multiple Sclerosis. Neurol Neuroimmunol Neuroinflammation Wolters Kluwer. 2024;11:e200253. https:\/\/doi.org\/10.1212\/NXI.0000000000200253.","journal-title":"Neurol Neuroimmunol Neuroinflammation Wolters Kluwer"},{"key":"1495_CR41","doi-asserted-by":"publisher","unstructured":"Meaton I, Altokhis A, Allen CM, Clarke MA, Sinnecker T, Meier D, Publications Ltd STM et al. 2022;28:2212\u201320. https:\/\/doi.org\/10.1177\/13524585221118677.","DOI":"10.1177\/13524585221118677"},{"key":"1495_CR42","doi-asserted-by":"publisher","first-page":"e210004","DOI":"10.1212\/WNL.0000000000210004","volume":"103","author":"JA Reeves","year":"2024","unstructured":"Reeves JA, Bartnik A, Jakimovski D, Mohebbi M, Bergsland N, Salman F, et al. Associations Between Paramagnetic Rim Lesion Evolution and Clinical and Radiologic Disease Progression in Persons With Multiple Sclerosis. Neurol Wolters Kluwer. 2024;103:e210004. https:\/\/doi.org\/10.1212\/WNL.0000000000210004.","journal-title":"Neurol Wolters Kluwer"},{"key":"1495_CR43","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1001\/jamaneurol.2020.0124","volume":"77","author":"S Suthiphosuwan","year":"2020","unstructured":"Suthiphosuwan S, Sati P, Absinta M, Guenette M, Reich DS, Bharatha A, et al. Paramagnetic Rim Sign in Radiologically Isolated Syndrome. JAMA Neurol. 2020;77:653\u20135. https:\/\/doi.org\/10.1001\/jamaneurol.2020.0124.","journal-title":"JAMA Neurol"},{"key":"1495_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/13524585221141964","volume":"29","author":"A Calvi","year":"2023","unstructured":"Calvi A, Clarke MA, Prados F, Chard D, Ciccarelli O, Alberich M, et al. Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis. Mult Scler Houndmills Basingstoke Engl. 2023;29:352\u201362. https:\/\/doi.org\/10.1177\/13524585221141964.","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"1495_CR45","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.ajo.2005.01.031","volume":"139","author":"AC Arnold","year":"2005","unstructured":"Arnold AC. Evolving Management of Optic Neuritis and Multiple Sclerosis. Am J Ophthalmol Elsevier. 2005;139:1101\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2005.01.031.","journal-title":"Am J Ophthalmol Elsevier"},{"key":"1495_CR46","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMcp053247","volume":"354","author":"LJ Balcer","year":"2006","unstructured":"Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med. 2006;354:1273\u201380. https:\/\/doi.org\/10.1056\/NEJMcp053247.","journal-title":"N Engl J Med"},{"key":"1495_CR47","doi-asserted-by":"publisher","first-page":"103429","DOI":"10.1016\/j.msard.2021.103429","volume":"57","author":"FE van der Feen","year":"2022","unstructured":"van der Feen FE, de Haan GA, van der Lijn I, Huizinga F, Meilof JF, Heersema DJ, et al. Recognizing visual complaints in people with multiple sclerosis: Prevalence, nature and associations with key characteristics of MS. Mult Scler Relat Disord. 2022;57:103429. https:\/\/doi.org\/10.1016\/j.msard.2021.103429.","journal-title":"Mult Scler Relat Disord"},{"key":"1495_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1212\/WNL.0000000000207625","volume":"101","author":"AT Toosy","year":"2023","unstructured":"Toosy AT, Vidal-Jordana A. Is the Optic Nerve Overdue as a Criterion to Support the Diagnosis of Multiple Sclerosis? Neurology. Wolters Kluwer. 2023;101:335\u20136. https:\/\/doi.org\/10.1212\/WNL.0000000000207625.","journal-title":"Wolters Kluwer"},{"key":"1495_CR49","doi-asserted-by":"publisher","first-page":"e784","DOI":"10.1212\/WNL.0000000000207507","volume":"101","author":"G Bsteh","year":"2023","unstructured":"Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Di Pauli F, et al. Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis. Neurol Wolters Kluwer. 2023;101:e784\u201393. https:\/\/doi.org\/10.1212\/WNL.0000000000207507.","journal-title":"Neurol Wolters Kluwer"},{"key":"1495_CR50","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1212\/WNL.0000000000011339","volume":"96","author":"A Vidal-Jordana","year":"2021","unstructured":"Vidal-Jordana A, Rovira A, Arrambide G, Otero-Romero S, R\u00edo J, Comabella M, et al. Optic Nerve Topography in Multiple Sclerosis Diagnosis: The Utility of Visual Evoked Potentials. Neurology. 2021;96:e482\u201390. https:\/\/doi.org\/10.1212\/WNL.0000000000011339.","journal-title":"Neurology"},{"key":"1495_CR51","doi-asserted-by":"publisher","first-page":"e200805","DOI":"10.1212\/WNL.0000000000207805","volume":"102","author":"A Vidal-Jordana","year":"2024","unstructured":"Vidal-Jordana A, Rovira A, Calderon W, Arrambide G, Castill\u00f3 J, Moncho D, et al. Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study. Neurology. 2024;102:e200805. https:\/\/doi.org\/10.1212\/WNL.0000000000207805.","journal-title":"Neurology"},{"key":"1495_CR52","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1474-4422(25)00275-3","volume":"24","author":"S Saidha","year":"2025","unstructured":"Saidha S, Green AJ, Leocani L, Vidal-Jordana A, Kenney RC, Bsteh G, et al. The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurol. 2025;24:880\u201392. https:\/\/doi.org\/10.1016\/S1474-4422(25)00275-3.","journal-title":"Lancet Neurol"},{"key":"1495_CR53","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","volume":"16","author":"A Petzold","year":"2017","unstructured":"Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, et al. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2017;16:797\u2013812. https:\/\/doi.org\/10.1016\/S1474-4422(17)30278-8.","journal-title":"Lancet Neurol"},{"key":"1495_CR54","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ana.25462","volume":"85","author":"RC Nolan-Kenney","year":"2019","unstructured":"Nolan-Kenney RC, Liu M, Akhand O, Calabresi PA, Paul F, Petzold A, et al. Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study. Ann Neurol. 2019;85:618\u201329. https:\/\/doi.org\/10.1002\/ana.25462.","journal-title":"Ann Neurol"},{"key":"1495_CR55","doi-asserted-by":"publisher","first-page":"e2468","DOI":"10.1212\/WNL.0000000000009504","volume":"94","author":"J-B Davion","year":"2020","unstructured":"Davion J-B, Lopes R, Drumez \u00c9, Labreuche J, Hadhoum N, Lannoy J, et al. Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS. Neurology. 2020;94:e2468\u201378. https:\/\/doi.org\/10.1212\/WNL.0000000000009504.","journal-title":"Neurology"},{"key":"1495_CR56","doi-asserted-by":"publisher","first-page":"e733","DOI":"10.1212\/WNL.0000000000009832","volume":"95","author":"O Outteryck","year":"2020","unstructured":"Outteryck O, Lopes R, Drumez \u00c9, Labreuche J, Lannoy J, Hadhoum N, et al. Optical coherence tomography for detection of asymptomatic optic nerve lesions in clinically isolated syndrome. Neurology. 2020;95:e733\u201344. https:\/\/doi.org\/10.1212\/WNL.0000000000009832.","journal-title":"Neurology"},{"key":"1495_CR57","doi-asserted-by":"publisher","first-page":"104416","DOI":"10.1016\/j.compbiomed.2021.104416","volume":"133","author":"A Montol\u00edo","year":"2021","unstructured":"Montol\u00edo A, Mart\u00edn-Gallego A, Cego\u00f1ino J, Orduna E, Vilades E, Garcia-Martin E, et al. Machine learning in diagnosis and disability prediction of multiple sclerosis using optical coherence tomography. Comput Biol Med. 2021;133:104416. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104416.","journal-title":"Comput Biol Med"},{"key":"1495_CR58","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/WNO.0000000000000704","volume":"38","author":"L Leocani","year":"2018","unstructured":"Leocani L, Guerrieri S, Comi G. Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc. 2018;38:350\u20137. https:\/\/doi.org\/10.1097\/WNO.0000000000000704.","journal-title":"J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc"},{"key":"1495_CR59","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41598-021-81826-z","volume":"11","author":"JM Miguel","year":"2021","unstructured":"Miguel JM, Rold\u00e1n M, P\u00e9rez-Rico C, Ortiz M, Boquete L, Blanco R. Using advanced analysis of multifocal visual-evoked potentials to evaluate the risk of clinical progression in patients with radiologically isolated syndrome. Sci Rep Nat Publishing Group. 2021;11:2036. https:\/\/doi.org\/10.1038\/s41598-021-81826-z.","journal-title":"Sci Rep Nat Publishing Group"},{"key":"1495_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121\u20137. https:\/\/doi.org\/10.1002\/ana.1032.","journal-title":"Ann Neurol"},{"key":"1495_CR61","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/brain\/awz144","volume":"142","author":"M Filippi","year":"2019","unstructured":"Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019;142:1858\u201375. https:\/\/doi.org\/10.1093\/brain\/awz144.","journal-title":"Brain"},{"key":"1495_CR62","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1177\/1352458515604905","volume":"22","author":"H Kearney","year":"2016","unstructured":"Kearney H, Miszkiel KA, Yiannakas MC, Altmann DR, Ciccarelli O, Miller DH. Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis. Mult Scler J. 2016;22:910\u201320. https:\/\/doi.org\/10.1177\/1352458515604905.","journal-title":"Mult Scler J"},{"key":"1495_CR63","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S1474-4422(03)00504-0","volume":"2","author":"G Lycklama","year":"2003","unstructured":"Lycklama G, Thompson A, Filippi M, Miller D, Polman C, Fazekas F, et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol. 2003;2:555\u201362. https:\/\/doi.org\/10.1016\/S1474-4422(03)00504-0.","journal-title":"Lancet Neurol"},{"key":"1495_CR64","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1177\/1352458512442754","volume":"18","author":"K Weier","year":"2012","unstructured":"Weier K, Mazraeh J, Naegelin Y, Thoeni A, Hirsch JG, Fabbro T, et al. Biplanar MRI for the assessment of the spinal cord in multiple sclerosis. Mult Scler J. 2012;18:1560\u20139. https:\/\/doi.org\/10.1177\/1352458512442754.","journal-title":"Mult Scler J"},{"key":"1495_CR65","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","volume":"18","author":"O Ciccarelli","year":"2019","unstructured":"Ciccarelli O, Cohen JA, Reingold SC, Weinshenker BG, Amato MP, Banwell B, et al. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. Lancet Neurol. 2019;18:185\u201397. https:\/\/doi.org\/10.1016\/S1474-4422(18)30460-5.","journal-title":"Lancet Neurol"},{"key":"1495_CR66","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(14)70294-7","volume":"14","author":"A Gass","year":"2015","unstructured":"Gass A, Rocca MA, Agosta F, Ciccarelli O, Chard D, Valsasina P, et al. MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis. Lancet Neurol. 2015;14:443\u201354. https:\/\/doi.org\/10.1016\/S1474-4422(14)70294-7.","journal-title":"Lancet Neurol"},{"key":"1495_CR67","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/cei.13641","volume":"206","author":"F Bartels","year":"2021","unstructured":"Bartels F, Lu A, Oertel FC, Finke C, Paul F, Chien C. Clinical and neuroimaging findings in MOGAD\u2013MRI and OCT. Clin Exp Immunol. 2021;206:266\u201381. https:\/\/doi.org\/10.1111\/cei.13641.","journal-title":"Clin Exp Immunol"},{"key":"1495_CR68","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1212\/WNL.0b013e31820d8b1d","volume":"76","author":"DT Okuda","year":"2011","unstructured":"Okuda DT, Mowry EM, Cree BAC, Crabtree EC, Goodin DS, Waubant E, et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology. 2011;76:686\u201392. https:\/\/doi.org\/10.1212\/WNL.0b013e31820d8b1d.","journal-title":"Neurology"},{"key":"1495_CR69","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1093\/brain\/awad073","volume":"146","author":"C Lebrun-Fr\u00e9nay","year":"2023","unstructured":"Lebrun-Fr\u00e9nay C, Okuda DT, Siva A, Landes-Chateau C, Azevedo CJ, Mondot L, et al. The radiologically isolated syndrome: revised diagnostic criteria. Brain. 2023;146:3431\u201343. https:\/\/doi.org\/10.1093\/brain\/awad073.","journal-title":"Brain"},{"key":"1495_CR70","doi-asserted-by":"publisher","first-page":"e90509","DOI":"10.1371\/journal.pone.0090509","volume":"9","author":"DT Okuda","year":"2014","unstructured":"Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS ONE. 2014;9:e90509. https:\/\/doi.org\/10.1371\/journal.pone.0090509.","journal-title":"PLoS ONE"},{"key":"1495_CR71","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1177\/1352458519864933","volume":"26","author":"I Dekker","year":"2020","unstructured":"Dekker I, Sombekke MH, Balk LJ, Moraal B, Geurts JJ, Barkhof F, et al. Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability? Mult Scler J. 2020;26:1381\u201391. https:\/\/doi.org\/10.1177\/1352458519864933.","journal-title":"Mult Scler J"},{"key":"1495_CR72","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00401-024-02700-6","volume":"147","author":"AD Waldman","year":"2024","unstructured":"Waldman AD, Catania C, Pisa M, Jenkinson M, Lenardo MJ, DeLuca GC. The prevalence and topography of spinal cord demyelination in multiple sclerosis: a retrospective study. Acta Neuropathol (Berl). 2024;147:51. https:\/\/doi.org\/10.1007\/s00401-024-02700-6.","journal-title":"Acta Neuropathol (Berl)"},{"key":"1495_CR73","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1093\/brain\/awz156","volume":"142","author":"WJ Brownlee","year":"2019","unstructured":"Brownlee WJ, Altmann DR, Prados F, Miszkiel KA, Eshaghi A, Gandini Wheeler-Kingshott CAM, et al. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis. Brain J Neurol. 2019;142:2276\u201387. https:\/\/doi.org\/10.1093\/brain\/awz156.","journal-title":"Brain J Neurol"},{"key":"1495_CR74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ensci.2018.07.002","volume":"12","author":"A Dastagir","year":"2018","unstructured":"Dastagir A, Healy BC, Chua AS, Chitnis T, Weiner HL, Bakshi R, et al. Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis. eNeurologicalSci. 2018;12:42\u20136. https:\/\/doi.org\/10.1016\/j.ensci.2018.07.002.","journal-title":"eNeurologicalSci"},{"key":"1495_CR75","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/ana.27145","volume":"97","author":"WJ Brownlee","year":"2025","unstructured":"Brownlee WJ, Vidal-Jordana A, Shatila M, Strijbis E, Schoof L, Killestein J, et al. Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis. Ann Neurol. 2025;97:571\u201382. https:\/\/doi.org\/10.1002\/ana.27145.","journal-title":"Ann Neurol"},{"key":"1495_CR76","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/brain\/awy006","volume":"141","author":"G Arrambide","year":"2018","unstructured":"Arrambide G, Tintore M, Espejo C, Auger C, Castillo M, R\u00edo J, et al. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria. Brain. 2018;141:1075\u201384. https:\/\/doi.org\/10.1093\/brain\/awy006.","journal-title":"Brain"},{"key":"1495_CR77","doi-asserted-by":"publisher","first-page":"105035","DOI":"10.1016\/j.msard.2023.105035","volume":"79","author":"M Forcadela","year":"2023","unstructured":"Forcadela M, Birch K, Rocchi C, Campagna G, Jackson E, Chadwick C, et al. Do we still need OCBs in MS diagnosis and how many? Mult Scler Relat Disord. 2023;79:105035. https:\/\/doi.org\/10.1016\/j.msard.2023.105035.","journal-title":"Mult Scler Relat Disord"},{"key":"1495_CR78","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/10408363.2022.2039591","volume":"59","author":"S Carta","year":"2022","unstructured":"Carta S, Ferraro D, Ferrari S, Briani C, Mariotto S. Oligoclonal bands: clinical utility and interpretation cues. Crit Rev Clin Lab Sci Taylor Francis. 2022;59:391\u2013404. https:\/\/doi.org\/10.1080\/10408363.2022.2039591.","journal-title":"Crit Rev Clin Lab Sci Taylor Francis"},{"key":"1495_CR79","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00415-011-6221-8","volume":"259","author":"M Djukic","year":"2012","unstructured":"Djukic M, Schmidt-Samoa C, Lange P, Spreer A, Neubieser K, Eiffert H, et al. Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis. J Neurol. 2012;259:630\u20136. https:\/\/doi.org\/10.1007\/s00415-011-6221-8.","journal-title":"J Neurol"},{"key":"1495_CR80","doi-asserted-by":"publisher","unstructured":"Jel\u010di\u0107 I, Martin R. Chapter 6 - Biomarkers in Multiple Sclerosis. In: Lucchinetti CF, Hohlfeld R, editors. Blue Books Neurol. Butterworth-Heinemann; 2010. pp. 120\u201346. https:\/\/doi.org\/10.1016\/B978-1-4160-6068-0.00006-1.","DOI":"10.1016\/B978-1-4160-6068-0.00006-1"},{"key":"1495_CR81","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/13524585221134213","volume":"29","author":"H Hegen","year":"2023","unstructured":"Hegen H, Walde J, Berek K, Arrambide G, Gnanapavan S, Kaplan B, et al. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis. Mult Scler J. 2023;29:169\u201381. https:\/\/doi.org\/10.1177\/13524585221134213.","journal-title":"Mult Scler J"},{"key":"1495_CR82","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3390\/cells10113056","volume":"10","author":"FF Konen","year":"2021","unstructured":"Konen FF, Schwenkenbecher P, Jendretzky KF, Gingele S, S\u00fchs K-W, Tumani H, et al. The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis. Cells Multidisciplinary Digit Publishing Inst. 2021;10:3056. https:\/\/doi.org\/10.3390\/cells10113056.","journal-title":"Cells Multidisciplinary Digit Publishing Inst"},{"key":"1495_CR83","doi-asserted-by":"publisher","first-page":"105905","DOI":"10.1016\/j.ebiom.2025.105905","volume":"120","author":"F Deisenhammer","year":"2025","unstructured":"Deisenhammer F, Hegen H, Arrambide G, Banwell BL, Coetzee T, Gnanapavan S, et al. Positive cerebrospinal fluid in the 2024 McDonald criteria for multiple sclerosis. EBioMedicine. 2025;120:105905. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105905.","journal-title":"EBioMedicine"},{"key":"1495_CR84","doi-asserted-by":"publisher","first-page":"282","DOI":"10.21037\/atm-21-3073","volume":"11","author":"H Jin","year":"2023","unstructured":"Jin H, Lu Q, Gao F, Hao H. Application of oligoclonal bands and other cerebrospinal fluid variables in multiple sclerosis and other neuroimmunological diseases: a narrative review. Ann Transl Med AME Publishing Co. 2023;11:282\u2013282. https:\/\/doi.org\/10.21037\/atm-21-3073.","journal-title":"Ann Transl Med AME Publishing Co"},{"key":"1495_CR85","doi-asserted-by":"publisher","first-page":"111098","DOI":"10.1016\/j.clinbiochem.2026.111098","volume":"142","author":"V Higgins","year":"2026","unstructured":"Higgins V, Parker ML, Ahmed B, Bhayana V, Booth RA, Chen Y, et al. Best practice recommendations for laboratory analysis and reporting of cerebrospinal fluid oligoclonal banding and associated tests for multiple sclerosis (MS): a consensus report from the harmonized CSF analysis for MS investigation (hCAMI) subcommittee of the Canadian society of clinical chemists (CSCC). Clin Biochem. 2026;142:111098. https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111098.","journal-title":"Clin Biochem"},{"key":"1495_CR86","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1212\/WNL.0000000000011242","volume":"96","author":"T Kalincik","year":"2021","unstructured":"Kalincik T, Diouf I, Sharmin S, Malpas C, Spelman T, Horakova D, et al. Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years. Neurol Wolters Kluwer. 2021;96:e783\u201397. https:\/\/doi.org\/10.1212\/WNL.0000000000011242.","journal-title":"Neurol Wolters Kluwer"},{"key":"1495_CR87","doi-asserted-by":"publisher","unstructured":"Kavaliunas A, Manouchehrinia A, Stawiarz L, Ramanujam R, Agholme J, Hedstr\u00f6m AK, Publications Ltd STM et al. 2017;23:1233\u201340. https:\/\/doi.org\/10.1177\/1352458516675039.","DOI":"10.1177\/1352458516675039"},{"key":"1495_CR88","doi-asserted-by":"publisher","unstructured":"Iaffaldano P, Lucisano G, Butzkueven H, Hillert J, Hyde R, Koch-Henriksen N, Publications Ltd STM et al. 2021;27:1543\u201355. https:\/\/doi.org\/10.1177\/13524585211010128.","DOI":"10.1177\/13524585211010128"},{"key":"1495_CR89","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s40263-019-00647-x","volume":"33","author":"M F\u00f6rster","year":"2019","unstructured":"F\u00f6rster M, Graf J, Mares J, Aktas O, Hartung H-P, Kremer D. Drug Treatment of Clinically Isolated Syndrome. CNS Drugs. 2019;33:659\u201376. https:\/\/doi.org\/10.1007\/s40263-019-00647-x.","journal-title":"CNS Drugs"},{"key":"1495_CR90","doi-asserted-by":"publisher","first-page":"1190208","DOI":"10.3389\/fneur.2023.1190208","volume":"14","author":"S-J Martin","year":"2023","unstructured":"Martin S-J, Schneider R. Multiple sclerosis and exercise-A disease-modifying intervention of mice or men? Front Neurol. 2023;14:1190208. https:\/\/doi.org\/10.3389\/fneur.2023.1190208.","journal-title":"Front Neurol"},{"key":"1495_CR91","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jneuroim.2018.10.004","volume":"329","author":"M Alrouji","year":"2019","unstructured":"Alrouji M, Manouchehrinia A, Gran B, Constantinescu CS. Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis. J Neuroimmunol. 2019;329:24\u201334. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.10.004.","journal-title":"J Neuroimmunol"},{"key":"1495_CR92","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.bbi.2024.06.004","volume":"120","author":"S von Drathen","year":"2024","unstructured":"von Drathen S, Gold SM, Peper J, Rahn AC, Ramien C, Magyari M, et al. Stress and Multiple Sclerosis - Systematic review and meta-analysis of the association with disease onset, relapse risk and disability progression. Brain Behav Immun. 2024;120:620\u20139. https:\/\/doi.org\/10.1016\/j.bbi.2024.06.004.","journal-title":"Brain Behav Immun"},{"key":"1495_CR93","doi-asserted-by":"publisher","first-page":"105636","DOI":"10.1016\/j.msard.2024.105636","volume":"87","author":"EM Solsona","year":"2024","unstructured":"Solsona EM, Tektonidis T, Reece JC, Simpson-Yap S, Black LJ, Rad EY, et al. Associations between diet and disease progression and symptomatology in multiple sclerosis: A systematic review of observational studies. Mult Scler Relat Disord. 2024;87:105636. https:\/\/doi.org\/10.1016\/j.msard.2024.105636.","journal-title":"Mult Scler Relat Disord"},{"key":"1495_CR94","doi-asserted-by":"publisher","first-page":"e200289","DOI":"10.1212\/NXI.0000000000200289","volume":"11","author":"J Wu","year":"2024","unstructured":"Wu J, Olsson T, Hillert JA, Alfredsson L, Hedstr\u00f6m AK. Association Between Alcohol Consumption and Disability Accumulation in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflammation Wolters Kluwer. 2024;11:e200289. https:\/\/doi.org\/10.1212\/NXI.0000000000200289.","journal-title":"Neurol Neuroimmunol Neuroinflammation Wolters Kluwer"},{"key":"1495_CR95","doi-asserted-by":"publisher","first-page":"e16269","DOI":"10.1111\/ene.16269","volume":"31","author":"J Wu","year":"2024","unstructured":"Wu J, Olsson T, Alfredsson L, Hedstr\u00f6m AK. Association between sun exposure habits and disease progression in multiple sclerosis. Eur J Neurol. 2024;31:e16269. https:\/\/doi.org\/10.1111\/ene.16269.","journal-title":"Eur J Neurol"},{"key":"1495_CR96","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1177\/13524585211048401","volume":"28","author":"AJ Solomon","year":"2022","unstructured":"Solomon AJ, Kaisey M, Krieger SC, Chahin S, Naismith RT, Weinstein SM, et al. Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States. Mult Scler Houndmills Basingstoke Engl. 2022;28:1248\u201356. https:\/\/doi.org\/10.1177\/13524585211048401.","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"1495_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-025-01140-4","author":"AJ Solomon","year":"2025","unstructured":"Solomon AJ, Brodersen JB. The 2024 revisions of the McDonald criteria pose risk of multiple sclerosis overdiagnosis. Nat Rev Neurol. 2025. https:\/\/doi.org\/10.1038\/s41582-025-01140-4.","journal-title":"Nat Rev Neurol"},{"key":"1495_CR98","doi-asserted-by":"publisher","first-page":"e624","DOI":"10.1212\/WNL.0000000000207481","volume":"101","author":"AJ Solomon","year":"2023","unstructured":"Solomon AJ, Marrie RA, Viswanathan S, Correale J, Magyari M, Robertson NP, et al. Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third Edition. Neurology. 2023;101:e624\u201335. https:\/\/doi.org\/10.1212\/WNL.0000000000207481.","journal-title":"Neurology"},{"key":"1495_CR99","doi-asserted-by":"publisher","first-page":"1015256","DOI":"10.3389\/fneur.2022.1015256","volume":"13","author":"S Simoens","year":"2022","unstructured":"Simoens S. Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies. Front Neurol. 2022;13:1015256. https:\/\/doi.org\/10.3389\/fneur.2022.1015256.","journal-title":"Front Neurol"},{"key":"1495_CR100","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung H, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol. 2005;58:840\u20136. https:\/\/doi.org\/10.1002\/ana.20703.","journal-title":"Ann Neurol"},{"key":"1495_CR101","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302. https:\/\/doi.org\/10.1002\/ana.22366.","journal-title":"Ann Neurol"},{"key":"1495_CR102","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","volume":"120","author":"F Barkhof","year":"1997","unstructured":"Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997;120:2059\u201369. https:\/\/doi.org\/10.1093\/brain\/120.11.2059.","journal-title":"Brain"},{"key":"1495_CR103","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ana.26555","volume":"93","author":"DT Okuda","year":"2023","unstructured":"Okuda DT, Kantarci O, Lebrun-Fr\u00e9nay C, Sormani MP, Azevedo CJ, Bovis F, et al. Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome. Ann Neurol. 2023;93:604\u201314. https:\/\/doi.org\/10.1002\/ana.26555.","journal-title":"Ann Neurol"},{"key":"1495_CR104","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2023.2815","volume":"80","author":"C Lebrun-Fr\u00e9nay","year":"2023","unstructured":"Lebrun-Fr\u00e9nay C, Siva A, Sormani MP, Landes-Chateau C, Mondot L, Bovis F, et al. Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial. JAMA Neurol. 2023;80:1080\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2023.2815.","journal-title":"JAMA Neurol"},{"key":"1495_CR105","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/bjhp.12341","volume":"24","author":"J Hanmer","year":"2019","unstructured":"Hanmer J, Yu L, Li J, Kavalieratos D, Peterson L, Hess R. The Diagnosis and Treatment of Asymptomatic Disease is Associated with Decreased Health-Related Quality of Life: A cross sectional analysis from the National Health and Nutrition Examination Survey. Br J Health Psychol. 2019;24:88\u2013101. https:\/\/doi.org\/10.1111\/bjhp.12341.","journal-title":"Br J Health Psychol"},{"key":"1495_CR106","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/1352458520910496","volume":"27","author":"AJ Solomon","year":"2021","unstructured":"Solomon AJ, Pettigrew R, Naismith RT, Chahin S, Krieger S, Weinshenker B. Challenges in multiple sclerosis diagnosis: Misunderstanding and misapplication of the McDonald criteria. Mult Scler Houndmills Basingstoke Engl. 2021;27:250\u20138. https:\/\/doi.org\/10.1177\/1352458520910496.","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"1495_CR107","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1212\/WNL.0000000000003152","volume":"87","author":"AJ Solomon","year":"2016","unstructured":"Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, et al. The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology. 2016;87:1393\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000003152.","journal-title":"Neurology"},{"key":"1495_CR108","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/jnnp.2009.180000","volume":"82","author":"M Wasay","year":"2011","unstructured":"Wasay M, Rizvi F, Azeemuddin M, Yousuf A, Fredrikson S. Incidental MRI lesions suggestive of multiple sclerosis in asymptomatic patients in Karachi, Pakistan. J Neurol Neurosurg Psychiatry. 2011;82:83\u20135. https:\/\/doi.org\/10.1136\/jnnp.2009.180000.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1495_CR109","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1176\/jnp.8.1.54","volume":"8","author":"IK Lyoo","year":"1996","unstructured":"Lyoo IK, Seol HY, Byun HS, Renshaw PF. Unsuspected multiple sclerosis in patients with psychiatric disorders: a magnetic resonance imaging study. J Neuropsychiatry Clin Neurosci. 1996;8:54\u20139. https:\/\/doi.org\/10.1176\/jnp.8.1.54.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1495_CR110","doi-asserted-by":"publisher","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","volume":"365","author":"NA Patsopoulos","year":"2019","unstructured":"International Multiple Sclerosis Genetics Consortium, Patsopoulos NA, Baranzini SE, Santaniello A, Shoostari P, Cotsapas C, et al. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365:eaav7188. https:\/\/doi.org\/10.1126\/science.aav7188.","journal-title":"Science"},{"key":"1495_CR111","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45412","author":"Y Naji","year":"2023","unstructured":"Naji Y, Mahdaoui M, Klevor R, Kissani N. Artificial Intelligence and Multiple Sclerosis: Up-to-Date Review. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.45412.","journal-title":"Cureus"},{"key":"1495_CR112","unstructured":"Bierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. 8th Edition. Wiley-Blackwell; 2016."},{"key":"1495_CR113","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44\u20138. https:\/\/doi.org\/10.1002\/art.1780380107.","journal-title":"Arthritis Rheum"},{"key":"1495_CR114","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630\u201340. https:\/\/doi.org\/10.1002\/art.1780350606.","journal-title":"Arthritis Rheum"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01495-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-026-01495-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01495-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T09:26:37Z","timestamp":1777022797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-026-01495-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1495"],"URL":"https:\/\/doi.org\/10.1007\/s11910-026-01495-1","relation":{},"ISSN":["1534-6293"],"issn-type":[{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}